Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. J of Skin [Internet]. 2020 Jan. 28 [cited 2025 Apr. 19];4(1):S5. Available from: https://skin.dermsquared.com/skin/article/view/809